Literature DB >> 18616636

Repression of the SUMO-specific protease Senp1 induces p53-dependent premature senescence in normal human fibroblasts.

Kristin E Yates1, Gregory A Korbel, Michael Shtutman, Igor B Roninson, Daniel DiMaio.   

Abstract

The proliferative lifespan of normal somatic human cells in culture terminates in a permanent growth-arrested state known as replicative senescence. In this study, we show that RNA interference-mediated repression of the genes encoding the small ubiquitin-related modifier (SUMO)-specific proteases, Senp1, Senp2, and Senp7, induced low passage primary human fibroblasts to senesce rapidly. Following Senp1 repression, we observed a global increase in sumoylated proteins and in the number and size of nuclear SUMO-containing promyelocytic leukemia (PML) bodies. SUMO/PML bodies also increased during replicative senescence. p53 transcriptional activity was enhanced towards known p53 target genes following repression of Senp1, and inhibition of p53 function prevented senescence after Senp1 repression. These data indicate that Senp1 repression induces p53-mediated premature senescence and that SUMO proteases may thus be required for proliferation of normal human cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18616636      PMCID: PMC2745089          DOI: 10.1111/j.1474-9726.2008.00411.x

Source DB:  PubMed          Journal:  Aging Cell        ISSN: 1474-9718            Impact factor:   9.304


  72 in total

1.  Herpes simplex virus 1 ICP0 co-localizes with a SUMO-specific protease.

Authors:  Daniel Bailey; Peter O'Hare
Journal:  J Gen Virol       Date:  2002-12       Impact factor: 3.891

2.  Senescence-associated beta-galactosidase is lysosomal beta-galactosidase.

Authors:  Bo Yun Lee; Jung A Han; Jun Sub Im; Amelia Morrone; Kimberly Johung; Edward C Goodwin; Wim J Kleijer; Daniel DiMaio; Eun Seong Hwang
Journal:  Aging Cell       Date:  2006-04       Impact factor: 9.304

3.  The SUMO-specific protease SENP5 is required for cell division.

Authors:  Alessandra Di Bacco; Jian Ouyang; Hsiang-Ying Lee; Andre Catic; Hidde Ploegh; Grace Gill
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 4.  SUMO is growing senescent.

Authors:  Oliver Bischof; Anne Dejean
Journal:  Cell Cycle       Date:  2007-03-20       Impact factor: 4.534

Review 5.  Modification in reverse: the SUMO proteases.

Authors:  Debaditya Mukhopadhyay; Mary Dasso
Journal:  Trends Biochem Sci       Date:  2007-05-17       Impact factor: 13.807

Review 6.  Genetic progress towards the molecular basis of autoimmunity.

Authors:  Simon H S Pearce; Tony R Merriman
Journal:  Trends Mol Med       Date:  2006-01-18       Impact factor: 11.951

7.  The senescent side of tumor suppression.

Authors:  Manuel Collado; Manuel Serrano
Journal:  Cell Cycle       Date:  2005-12-18       Impact factor: 4.534

8.  MDM2-ARF complex regulates p53 sumoylation.

Authors:  Lihong Chen; Jiandong Chen
Journal:  Oncogene       Date:  2003-08-14       Impact factor: 9.867

9.  RBP1 family proteins exhibit SUMOylation-dependent transcriptional repression and induce cell growth inhibition reminiscent of senescence.

Authors:  Olivier Binda; Jean-Sébastien Roy; Philip E Branton
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

10.  The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.

Authors:  Oliver Bischof; Klaus Schwamborn; Nadine Martin; Andreas Werner; Claudio Sustmann; Rudolf Grosschedl; Anne Dejean
Journal:  Mol Cell       Date:  2006-06-23       Impact factor: 17.970

View more
  35 in total

1.  SUMO-specific protease 2 in Mdm2-mediated regulation of p53.

Authors:  M Jiang; S-Y Chiu; W Hsu
Journal:  Cell Death Differ       Date:  2010-12-24       Impact factor: 15.828

2.  SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML.

Authors:  Domenico Fasci; Veronica G Anania; Jennie R Lill; Guy S Salvesen
Journal:  Sci Signal       Date:  2015-06-09       Impact factor: 8.192

3.  Primary human cervical carcinoma cells require human papillomavirus E6 and E7 expression for ongoing proliferation.

Authors:  Thomas G Magaldi; Laura L Almstead; Stefania Bellone; Edward G Prevatt; Alessandro D Santin; Daniel DiMaio
Journal:  Virology       Date:  2011-11-05       Impact factor: 3.616

4.  Chronic stress induces ageing-associated degeneration in rat Leydig cells.

Authors:  Fei-Fei Wang; Qian Wang; Yong Chen; Qiang Lin; Hui-Bao Gao; Ping Zhang
Journal:  Asian J Androl       Date:  2012-05-21       Impact factor: 3.285

Review 5.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

6.  NFBD1/MDC1 regulates Cav1 and Cav2 independently of DNA damage and p53.

Authors:  Kathleen A Wilson; Sierra A Colavito; Vincent Schulz; Patricia Heffernan Wakefield; William Sessa; David Tuck; David F Stern
Journal:  Mol Cancer Res       Date:  2011-05-06       Impact factor: 5.852

7.  Interactions of ErbB4 and Kap1 connect the growth factor and DNA damage response pathways.

Authors:  Maureen Gilmore-Hebert; Rajani Ramabhadran; David F Stern
Journal:  Mol Cancer Res       Date:  2010-09-21       Impact factor: 5.852

8.  The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment.

Authors:  Guillaume Dalmasso; Antony Cougnoux; Julien Delmas; Arlette Darfeuille-Michaud; Richard Bonnet
Journal:  Gut Microbes       Date:  2014

9.  Aberrant sumoylation signaling evoked by reactive oxygen species impairs protective function of Prdx6 by destabilization and repression of its transcription.

Authors:  Bhavana Chhunchha; Nigar Fatma; Eri Kubo; Dhirendra P Singh
Journal:  FEBS J       Date:  2014-07-01       Impact factor: 5.542

Review 10.  A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics.

Authors:  Ellen Van Damme; Kris Laukens; Thanh Hai Dang; Xaveer Van Ostade
Journal:  Int J Biol Sci       Date:  2010-01-12       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.